|
|
|
Volumn 309, Issue 5737, 2005, Pages 999-1000
|
|
Report of novel treatment aimed at latent HIV raises the 'c word'
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
HISTONE DEACETYLASE 1;
HISTONE DEACETYLASE INHIBITOR;
INTERLEUKIN 2;
VALPROIC ACID;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ENFUVIRTIDE;
ENZYME INHIBITOR;
GLYCOPROTEIN GP 41;
HDAC1 PROTEIN, HUMAN;
HISTONE DEACETYLASE;
PEPTIDE FRAGMENT;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PRIORITY JOURNAL;
ARTICLE;
CD4+ T LYMPHOCYTE;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
PHYSIOLOGY;
VIROLOGY;
VIRUS LATENCY;
HUMAN IMMUNODEFICIENCY VIRUS;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4-POSITIVE T-LYMPHOCYTES;
ENZYME INHIBITORS;
HISTONE DEACETYLASES;
HIV;
HIV ENVELOPE PROTEIN GP41;
HIV INFECTIONS;
HUMANS;
PEPTIDE FRAGMENTS;
VALPROIC ACID;
VIRUS LATENCY;
|
|
EID: 23644450063
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|